Clinical trial
High-dose Antioxidants for Central Serous Chorioretinopathy
NCT00963131 is registered in ClinicalTrials.gov with Prince of Songkla University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High-dose Antioxidants for Central Serous Chorioretinopathy
- Lead sponsor
- Prince of Songkla University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2004
- Completion date
- June 30, 2009
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.